CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS)

£24.00

+ Free Shipping
Category:

Buy CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS) in the UK

For customers researching fertility medicines in the United Kingdom, understanding the active ingredient, approved uses, formulation, and responsible handling is essential. CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS) contains clomifene citrate, a medicine used in selected cases of ovulatory failure. UK product information states that clomifene is intended for women who wish to become pregnant when ovulatory dysfunction has been identified. (Medicines.org.uk)

Understanding Clomifene Citrate

Clomifene citrate belongs to a group of medicines used to stimulate ovulation. Its action involves influencing oestrogen signalling, which can encourage the pituitary gland to release hormones involved in follicular development and ovulation. Because infertility can have many causes, UK prescribing information recommends evaluating other potential causes before treatment begins. (Medicines.org.uk)

The 50 mg strength is an established tablet formulation. Each tablet contains 50 mg of clomifene citrate, while the inactive ingredients depend on the specific manufacturer and presentation. Customers should always check the official product information supplied with their particular pack. (Medicines.org.uk)

Intended Medical Use

In the UK, clomifene is primarily associated with ovulation induction in carefully selected patients experiencing ovulatory problems. It is not a general fertility supplement and should not be used simply because conception has taken longer than expected. A healthcare professional should establish whether impaired ovulation is contributing to infertility and determine whether this medicine is appropriate. (Medicines.org.uk)

NHS fertility guidance explains that treatment is generally given for a limited period early in the menstrual cycle. Clinical monitoring may be used to confirm that follicles are developing appropriately and that excessive ovarian stimulation is not occurring. (ASPH)

Product Strength and Presentation

This listing refers to a 50 mg tablet strength and a stated presentation of 50 tablets. Packaging, tablet appearance, excipients, and available pack sizes can vary between manufacturers. For example, UK electronic medicines information identifies 50 mg clomifene tablets as an authorised medicinal presentation, while specific Clomid documentation lists its own packaging options. (Medicines.org.uk)

When considering any prescription medicine, customers should verify the product name, active ingredient, strength, manufacturer, expiry information, and packaging before use. The MHRA provides access to official medicine information, including Patient Information Leaflets and Summaries of Product Characteristics.

Responsible Use

Clomifene should be taken exactly as prescribed by a qualified healthcare professional. UK product information describes treatment in courses and stresses that patients should not increase the dose or extend treatment independently. The recommended regimen depends on the individual clinical situation and response to therapy

Patients should discuss existing medical conditions and other medicines with their doctor or pharmacist before starting treatment. The UK patient leaflet specifically highlights conditions including liver disease, unexplained menstrual bleeding, ovarian cysts, certain hormone-sensitive cancers, and previous vision problems associated with treatment. It also states that the medicine should not be taken during pregnancy.

Possible Side Effects and Monitoring

As with other prescription medicines, clomifene can cause unwanted effects. Reported problems can include headaches, hot flushes, abdominal discomfort, breast tenderness, mood changes, dizziness, and visual disturbances. More serious complications can occur, including ovarian hyperstimulation, which requires prompt medical attention.

Vision changes are particularly important. The UK patient information advises patients experiencing visual problems to stop activities such as driving or operating machinery and seek medical advice. Sudden or severe symptoms should receive urgent medical assessment.

Treatment can also increase the likelihood of multiple pregnancy. NHS information notes that twins are more common following ovulation-induction treatment, making appropriate clinical supervision important. (DBTH Hospitals)

Choosing a UK-Focused Medicine Supplier

When researching CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS) online, customers should prioritise accurate product information, transparent packaging details, secure ordering processes, and responsible medicine guidance. Prescription fertility medicines should only be obtained and used through lawful channels and under appropriate medical supervision.

A trustworthy product page should clearly identify the active ingredient and strength while avoiding unsupported claims about fertility outcomes. It should also encourage customers to consult a doctor or pharmacist when they have questions about suitability, interactions, contraindications, or side effects.

Final Considerations

Clomifene citrate has an established role in fertility care for selected women with ovulatory dysfunction. Its use requires appropriate diagnosis, individualised prescribing, and attention to safety information. The UK medicines information recommends professional supervision rather than self-directed dose changes or prolonged treatment. (Medicines.org.uk)

For UK customers researching CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS), accurate information should remain the priority. Check the official leaflet, confirm the medicine and strength, follow the prescribed instructions, and speak with a qualified healthcare professional whenever uncertainty exists. This approach supports informed decisions while keeping fertility treatment aligned with established UK medical guidance.

CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS)CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS)

Reviews

There are no reviews yet.

Be the first to review “CLOMIPHENE CITRATE (CLOMID) (50 MG/TAB. – 50 TABS)”

Your email address will not be published. Required fields are marked *

Shopping Cart